Volume 30, Number 11—November 2024
Synopsis
Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008–2019
Sarah Gorvetzian1, Antonio G. Pacheco, Erin Anderson, Susan M. Ray, and Marcos C. Schechter
Table 1
Characteristics of patients who finished TB treatment stratified according to posttreatment death, HIV infection, and place of birth in study of mortality rates after TB treatment, Georgia, USA, 2008–2019*
| Characteristics | No. (%) patients |
|||
|---|---|---|---|---|
| Overall cohort | Posttreatment deaths | HIV positive | US-born persons | |
| Total no. patients |
3,218 |
233 |
328 |
1,557 |
| Age, y | ||||
| 18–44 | 1,595 (50) | 32 (2) | 183 (11) | 581 (36) |
| 45–64 | 1,147 (36) | 114 (10) | 135 (12) | 728 (63) |
| >65 |
440 (14) |
87 (20) |
10 (2) |
248 (56) |
| Sex | ||||
| F | 1,089 (34) | 70 (6) | 93 (9) | 477 (44) |
| M |
2,093 (66) |
163 (8) |
235 (11) |
1,080 (52) |
| Place of birth | ||||
| Non–US-born | 1,625 (51) | 32 (2) | 113 (7) | NA |
| US-born |
1,557 (49) |
201 (13) |
215 (14) |
NA |
| Ethnicity | ||||
| Non-Hispanic White | 420 (13) | 59 (14) | 14 (3) | 368 (88) |
| Non-Hispanic Asian | 669 (21) | 21 (3) | 18 (3) | 19 (3) |
| Non-Hispanic Black | 1,479 (46) | 142 (10) | 247 (17) | 1,112 (75) |
| Hispanic, all races | 559 (18) | 11 (2) | 40 (7) | 29 (5) |
| Other |
55 (2) |
0 (0) |
9 (16) |
29 (53) |
| HIV status | ||||
| Negative | 2,729 (86) | 180 (7) | NA | 1,292 (47) |
| Positive | 328 (10) | 38 (12) | NA | 215 (66) |
| Missing data |
125 (4) |
15 (12) |
NA |
50 (40) |
| Injection drug use | ||||
| No | 3,097 (97) | 227 (7) | 306 (10) | 1,509 (49) |
| Yes | 36 (1) | 4 (11) | 14 (39) | 33 (92) |
| Missing data |
49 (2) |
2 (4) |
8 (16) |
15 (31) |
| Excess alcohol use | ||||
| No | 2,659 (84) | 162 (6) | 257 (10) | 1,169 (44) |
| Yes | 467 (15) | 69 (15) | 65 (14) | 370 (79) |
| Missing data |
56 (2) |
2 (4) |
6 (11) |
18 (32) |
| Homeless within year before TB diagnosis | ||||
| No | 2,860 (90) | 187 (7) | 246 (9) | 1,294 (45) |
| Yes | 313 (10) | 45 (14) | 81 (26) | 262 (84) |
| Missing data |
9 (<1) |
1 (11) |
1 (11) |
1 (11) |
| Diabetes mellitus | ||||
| No | 2,791 (88) | 178 (6) | 319 (11) | 1,368 (48) |
| Yes |
391 (12) |
55 (14) |
9 (2) |
189 (49) |
| End-stage renal disease | ||||
| No | 3,139 (99) | 224 (7) | 324 (10) | 1,527 (49) |
| Yes | 43 (1) | 9 (21) | 4 (9) | 30 (70) |
*NA, not applicable; TB, tuberculosis.
1Current affiliation: University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Page created: September 12, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.